Search results
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 7 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 19 hours agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via Yahoo News· 1 day agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
Gateway - Quartz
Quartz· 23 hours agoHealthcare companies including Ro and Eli Lilly are introducing online supply trackers to help patients navigate ongoing GLP-1 drug shortages. Moderna says it is in talks ...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 5 days agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination vaccines have been successfully ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Gateway - Quartz
Quartz· 1 day agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 5 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Gateway - Quartz
Quartz· 8 hours agoLike many other wealthy nations, the country bought many more vaccines than it needed—a total of nearly 32 million—to account for potential quality issues, or supply delays. This week, the nation ...
